Worth reading
45Recurring
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
発行済株式総数
0.00% (for exercises during the target month)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Number of Stock Acquisition Rights
Total number issued: 140,000 rights; unexercised rights outstanding at the end of the month preceding the target month: 108,900; unexercised rights outstanding at the end of the target month: 0
Reason for acquisition without consideration
All 108,900 outstanding rights were acquired on 27 August 2026 and all cancelled on 28 August 2026
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
13th Stock Acquisition Rights issued on 14 October 2025 (with an exercise price adjustment clause)
| Item | Details |
|---|---|
| Type of issuance or disposal | 13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Dilution Rate | 0.00% (for exercises during the target month) |
| Total number of issued shares | 49,248,593 shares (at the end of July 2026) → Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 140,000 rights; unexercised rights outstanding at the end of the month preceding the target month: 108,900; unexercised rights outstanding at the end of the target month: 0 |
| Reason for acquisition without consideration | All 108,900 outstanding rights were acquired on 27 August 2026 and all cancelled on 28 August 2026 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 13th Stock Acquisition Rights issued on 14 October 2025 (with an exercise price adjustment clause) |
Items this document does not state (21)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise priceExercise periodTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company acquired all 108,900 outstanding 13th Stock Acquisition Rights on 27 August 2026 and cancelled all of them on 28 August 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.